Key Takeaways & Executive Findings
- •• This correction rectifies the affiliation of co-author Gloria Leon-Avila, ensuring accurate attribution in the scientific record. • The correction maintains the integrity of the original research on thymic epithelial cell expansion and thymosphere formation. • Accurate author affiliations are crucial for reproducibility and proper credit in biomedical research. • The correction underscores the importance of meticulous proofreading in academic publishing.
Abstract
The original article contains an erroneous attribution of co-author, Gloria Leon-Avila to affiliation #3. Dr Leon-Avila should instead be affiliated to affiliation #2 as shown in this correction article.
1. Introduction
This article is a correction to the original research article titled 'Primary explants of the postnatal thymus allow the expansion of clonogenic thymic epithelial cells that constitute thymospheres' published in Stem Cell Research & Therapy (2023) 14:312. The correction addresses an error in the attribution of co-author Gloria Leon-Avila, who was incorrectly listed under affiliation #3. The correct affiliation for Dr. Leon-Avila is affiliation #2, as detailed in this correction.
The original study focused on the expansion of clonogenic thymic epithelial cells from postnatal thymus explants, which form structures known as thymospheres. These findings have significant implications for understanding thymic biology and potential therapeutic applications. This correction ensures that the author affiliations are accurately represented, maintaining the credibility and transparency of the published work.
Loading authentic research manuscript (Pages 1–5)...
Juan M. Ocampo-Godinez, Jose L. Gonzalez-Quiroz, Hector Cote-Palafox, Elizabeth George, Jael A. Vergara-Lope Nuñez, Guillermo Villagomez-Olea, Febe C. Vazquez-Vazquez, Edgar O. Lopez-Villegas, Gloria Leon-Avila, Maria L. Dominguez-Lopez, Marco A. Alvarez-Perez (2026). Correction: Primary explants of the postnatal thymus allow the expansion of clonogenic thymic epithelial cells that constitute thymospheres. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-024-03665-9
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the purpose of this correction article?
The purpose is to correct an erroneous affiliation for co-author Gloria Leon-Avila in the original article, ensuring accurate attribution.
What was the original article about?
The original article described the expansion of clonogenic thymic epithelial cells from postnatal thymus explants, which form thymospheres.
Which affiliation was incorrectly assigned?
Gloria Leon-Avila was incorrectly assigned to affiliation #3; she should be affiliated with affiliation #2.
Does this correction affect the scientific findings of the original study?
No, the correction only addresses author affiliation and does not alter the scientific content or conclusions of the original study.
Where can I find the original article?
The original article can be found online at https://doi.org/10.1186/s13287-023-03529-8.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.